Aptose Prioritizes Development of CG’806 First-in Class FLT3/BTK Inhibitor

Jan 23, 2017 7:00am EST

Aptose Biosciences to Present at Biotech Showcase 2017 Conference

Jan 05, 2017 8:00am EST

Aptose Biosciences Provides Update on APTO-253 Development

Dec 29, 2016 8:00am EST

Aptose Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2016

Nov 14, 2016 7:22pm EST

Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016

Nov 10, 2016 7:00am EST

Aptose to Present New APTO-253 Data at the 2016 ASH Annual Meeting

Nov 03, 2016 4:15pm EDT

Aptose Provides Update on FDA Clinical Hold of APTO-253

Oct 13, 2016 7:00am EDT

Aptose Submits Formal Response to Clinical Hold for APTO-253

Sep 12, 2016 8:00am EDT

Aptose Biosciences Reports Financial Results for the Second Quarter Ended June 30, 2016

Aug 09, 2016 4:15pm EDT

Aptose Biosciences to Present at Canaccord Genuity 36th Annual Growth Conference

Aug 09, 2016 8:00am EDT